psychosis

Psychosis is a condition that affects a person’s mind and causes changes to the way that they think, feel and behave. A person who experiences psychosis may be unable to distinguish between reality and their imagination. People who are experiencing psychosis are sometimes referred to as psychotic. They may have hallucinations (where you see or hear things that are not there) and/or delusions (where you believe things that are untrue).

Our psychosis Blogs

City limits: untreated psychosis in the Global South

No Responses »
Profile photo of Izah Bowes
Posted by
james-wiseman-IebZAH6kaNw-unsplash

Izah Bowes considers a cross-sectional study exploring urbanicity and rates of untreated psychotic disorders in three diverse settings in the Global South: Trinidad, India and Nigeria.

[read the full story...]

Age-at-migration and ethnicity may increase psychosis risk

No Responses »
Profile photo of Sueda Coskun
Posted by
A young person smiling

Sueda Coskun reflects on a recent case control study with data from five European countries, which suggests that migration during adolescence may be a particular risk factor for developing psychosis.

[read the full story...]

We need to improve sleep assessment and treatment in patients with severe mental illness

No Responses »
Profile photo of Emiliana Tonini
Posted by
feat

Emiliana Tonini looks at how sleep is recorded and treated in people with serious mental illness—and how it affects their engagement with services. The study finds that sleep is rarely part of routine clinical assessment, and recommended sleep treatments are hardly ever used.

[read the full story...]

Cannabis legalisation: what can we learn about psychosis risk from the great Canadian (quasi) experiment?

No Responses »
Profile photo of Shuichi Suetani
Posted by
Marijuana,Or,Cannabis,With,Maple,Leaf

What happens to psychosis risk when cannabis becomes easier to access? According to this Canadian study, the risk goes up. Shuichi Suetani explores what we can learn from one of the countries leading the way in drug policy reform.

[read the full story...]

Continuing antipsychotic medication during pregnancy associated with reduced risk of schizophrenia relapse

No Responses »
Profile photo of Shuichi Suetani
Posted by
>,
A pregnant woman

Shuichi Suetani and Sarah Thomas highlight new research from Korea which suggests that antipsychotic medications do seem to help reduce the relapse of schizophrenia in pregnant women.

[read the full story...]

“Dem sey mi mad”: Afro Caribbean Experiences of Psychosis

No Responses »
Profile photo of Hári Sewell
Posted by
The findings suggest that the burnout measure successfully discriminated burnout from depression and anxiety symptoms.

Hári Sewell explores Afro Caribbean men’s experiences of psychosis, social and migration difficulties, and challenges accessing mental health services in North America and the United Kingdom.

[read the full story...]

Patterns of inflammation in childhood and mental and cardiometabolic disorders in adulthood: mapping the trajectories

No Responses »
Profile photo of Ruby Tsang
Posted by
feature

Ruby Tsang summarises a recent longitudinal study of trajectories of inflammation in youth and risk of mental and cardiometabolic disorders in adulthood, which finds that high levels of inflammation in childhood may be linked to an increased risk of psychosis, depression and insulin resistance in early adulthood.

[read the full story...]

HRT associated with reduced risk of psychosis relapse in middle-age women

No Responses »
Profile photo of Laura Naysmith
Posted by
Close,Up,Head,And,Shoulders,View,Of,Older,Woman,In

Laura Naysmith summarises a study of menopausal hormone therapy (also known as HRT), which suggests the treatment is linked with reduce the risk of psychosis relapse in menopausal women.

[read the full story...]

Omega-3 supplements for the prevention of psychosis: another trial shows no benefit, so is it time to move on?

No Responses »
Profile photo of David Mongan
Posted by
Feature

David Mongan reports on a recent trial of omega-3 supplementation for the prevention of psychosis in people at ultra-high risk, which finds no evidence of a positive effect. He reflects on these findings and considers what’s next for the field.

[read the full story...]